TRxADE HEALTH, Inc. (MEDS): Stock Price

The financial stability of TRxADE HEALTH, Inc. (MEDS) remains steady, although profit depends on wholesale supply volumes for the pharmacy sector and service implementation costs. Revenue is based on drug delivery commissions, marketplace operations, and telemedicine, with the key metric being 0.75. The available price action vector on GURU.Markets illustrates the dynamics of a business creating a B2B system for the digital optimization of pharmaceutical procurement.

MEDS - TRxADE HEALTH, Inc. Share Price over the range 07/04/2022 - 11/14/2026

Analytical breakdowns and data insights for company TRxADE HEALTH Inc (MEDS)

- stock value and consensus price forecast:

Price Chart TRxADE HEALTH, Inc.|MEDS - Consensus Target

- stock exchange capitalization data:

Market Capitalization TRxADE HEALTH Inc|MEDS - Total Enterprise Value

- book capitalization information:

Book Value per Share TRxADE HEALTH|MEDS - Accounting Capitalization|Market Value to Book Value Ratio trxadehealth.com|MEDS - Company Total Asset Base

- debt level and financial liquidity data:

- earnings and market ratios statistics:

MEDS - Company Net Income|Projected Future Earnings TRxADE HEALTH, Inc.|MEDS - Price to Earnings Multiple|Projected Price to Earnings TRxADE HEALTH|MEDS - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TRxADE HEALTH Inc|MEDS - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months TRxADE HEALTH|MEDS - Earnings per share for the last 12 months|Quarterly EPS earnings growth trxadehealth.com|MEDS - Earnings growth in current year|Earnings growth forecast for next year TRxADE HEALTH, Inc.

- sales revenue and business income indicators:

MEDS - Company Sales Volume|Projected Sales Volume TRxADE HEALTH, Inc.|MEDS - Price to Sales|Forward Price-to-Revenue Multiple TRxADE HEALTH Inc

Summary company analysis:TRxADE HEALTH, Inc. MEDS

The transformation of TRxADE HEALTH (MEDS) into the healthcare IT sector amid fierce competition makes the quotes of market assets a sensitive indicator of confidence in the new business model. This metric captures the daily balance of supply and demand, reflecting the current market value of equity, which allows investors to assess asset accumulation phases before determining the vector of further price action.

Direct competitors